CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zoetis Inc Company Snapshot
Zoetis Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zoetis Inc with three other companies in this sector in UNITED STATES : Alexion Pharmaceuticals, Inc. (2019 sales of $4.95 billion of which 80% was Soliris), Eisai Company Limited ($5.79 billion of which 88% was Pharmaceutical Business), and Perrigo Company PLC ($4.84 billion of which 51% was CSCA).

Sales Analysis. During the year ended December of 2019, sales at Zoetis Inc were $6.26 billion. This is an increase of 7.5% versus 2018, when the company's sales were $5.83 billion. This was the fourth straight year of sales growth at Zoetis Inc. Sales of Contract Manufacturing saw an increase that was more than double the company's growth rate: sales were up 46.6% in 2019, from $58.00 million to $85.00 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zoetis Inc
  Stock Performance Chart for Zoetis Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 163.49
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 1.6%  
4 Weeks 13.4%   52 Weeks 31.5%  
 
Zoetis Inc Key Data:
  Ticker: ZTS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 6,260,000,000
(Year Ending Jan 2020).
Employees: 10,600
  Currency: U.S. Dollars Market Cap: 77,657,664,658
  Fiscal Yr Ends: December Shares Outstanding: 474,999,478
  Share Type: Class A Common Closely Held Shares: 1,171,338
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.